0001192482-21-000434.txt : 20210517
0001192482-21-000434.hdr.sgml : 20210517
20210517160758
ACCESSION NUMBER: 0001192482-21-000434
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210420
FILED AS OF DATE: 20210517
DATE AS OF CHANGE: 20210517
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ashton William
CENTRAL INDEX KEY: 0001474553
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36329
FILM NUMBER: 21930525
MAIL ADDRESS:
STREET 1: C/O HARRISON CONSULTING GROUP
STREET 2: PO BOX 283
CITY: NEWTOWN SQUARE
STATE: PA
ZIP: 19073
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Recro Pharma, Inc.
CENTRAL INDEX KEY: 0001588972
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261523233
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 E. UWCHLAN AVE, SUITE 112
CITY: EXTON
STATE: PA
ZIP: 19341
BUSINESS PHONE: 770-534-8239
MAIL ADDRESS:
STREET 1: 1 E. UWCHLAN AVE, SUITE 112
CITY: EXTON
STATE: PA
ZIP: 19341
4/A
1
edgar.xml
PRIMARY DOCUMENT
X0306
4/A
2021-04-20
2021-04-22
0001588972
Recro Pharma, Inc.
REPH
0001474553
Ashton William
C/O RECRO PHARMA, INC.
490 LAPP ROAD
MALVERN
PA
19355
1
0
0
0
Stock Option (right to buy)
2.6
2021-04-20
4
A
0
38012
0
A
2031-04-20
Common Stock
38012
38012
D
This amended Form 4 is being filed to correct a typographical error in the exercise price of the stock options acquired on April 20, 2021 as reported on the Form 4 filed on April 22, 2021.
The stock option will vest on April 20, 2022.
/s/ Ryan D. Lake, Attorney-in-fact
2021-05-17